Brief: Windtree Therapeutics Posts Quarterly Loss Per Share Of $0.31
Nov 10 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES KEY BUSINESS UPDATES
* WINDTREE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.31
Source text for Eikon: ID:nGNX11rty1
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study